HUM insiders

28 insiders have filed at HUM since 2023Q3: names, roles, reported stakes, and each person's buying and selling record from SEC Form 3/4/5 filings.

namerolereported stake% of companybuys (3y)sells (3y)
Broussard Bruce DChief Executive Officer110.1k0.091%
Rechtin James A.President & CEO28.3k0.023%1 buys $1.5M
Mellet CelesteChief Financial Officer24.3k0.02%
Diamond Susan MChief Financial Officer22.4k0.019%
Damelio Frank ADirector20.6k0.017%
Hilzinger Kurt JDirector19.4k0.016%
Ventura Joseph CChief Legal Officer17.4k0.014%
Martin AaronPresident, Medicare Advantage17.0k0.014%
Agrawal VishalChief Strat & Corp Dev Officer16.7k0.014%
Renaudin George IIPresident, Insurance16.6k0.014%
Dintenfass DavidPresident, Enterprise Growth14.1k0.012%
Deshpande SamirChief Information Officer14.0k0.012%
Fleming William KevinChief Corporate Aff. Officer11.8k0.01%
Shetty Sanjay KPresident, Centerwell11.7k0.01%1 buys $150k
O'Hara Michelle A.Chief Human Resources Officer9.5k<0.01%
Mehta JapanChief Information Officer7.7k<0.01%
Felter John-Paul W.SVP, Chief Accting Off & Cont.7.5k<0.01%
Huval Timothy S.Chief Administrative Officer7.1k<0.01%1 sells $949k
Mesquita Jorge S.Director4.1k<0.01%1 buys $200k
Mcdonald William J.Director2.3k<0.01%
Garratt John WDirector1.7k<0.01%
Feinberg David TDirector1.2k<0.01%
Smith Brad DDirector1.2k<0.01%
Smith GordonDirector765<0.01%
Katz KarenDirector590<0.01%
Frederick Wayne A.I.Director440<0.01%
Klevorn Marcy SDirector436<0.01%
Bono Raquel C.Director397<0.01%

Full register at boothcheck.com/insiders/HUM. Stakes are the newest reported Form 3/4/5 balances (they update only when insiders file). Sales counted include pre-scheduled plan sales, labeled. A filed record, not a forecast. Nothing here is investment advice.

HUM institutional holders · HUM research report